Retatrutide

Description

Retatrutide

Category: Metabolic / Peptide Agonist Research
Brand: NUVION™

Description:
Retatrutide (also known by the development code LY-3437943) is a synthetic triple-agonist peptide designed to activate three key metabolic hormone receptors: GLP-1, GIP, and glucagon. In clinical studies, Retatrutide has demonstrated potent effects on weight reduction, glucose regulation, and energy balance.

At NUVION™, each vial is manufactured under stringent GMP standards to ensure reproducible purity and structural fidelity. The peptide is lyophilized to preserve stability and bioactivity for long-term storage and experimental use.

Key Features:

• Triple-receptor agonist (GLP-1 / GIP / glucagon)
• 99% purity
• GMP-compliant synthesis and packaging
• Lyophilized powder form for extended shelf life
• Packaged and bottled in the USA using globally sourced precursors

Intended Use:
For laboratory and preclinical research only. Not for human or veterinary consumption, injection, or diagnostic use.